**Author Information** An event is serious (FDA MedWatch definition) when the patient outcome is:\* death\* life-threatening\* hospitalisation\* disability\* congenital anomaly\* requires intervention to prevent permanent impairment or damage

A 62-year-old woman developed acute respiratory distress syndrome secondary to *Strongyloides stercoralis* infection following administration of dexamethasone.

The woman was diagnosed with cervical cancer. Her chemotherapy regimen included administration of cisplatin/paclitaxel on day 1 followed by paclitaxel alone on days 8 and 15. She also received dexamethasone \[*route not stated*\] at a dose of 16.5mg on days 1, 8 and 15 and 13.2mg on day 2 of the chemotherapeutic cycle. She reported of diarrhoea and vomiting in association with the high doses of corticosteroids; consequently, further chemotherapy was stopped after day 1 of the second cycle. Two months later, she reported of dyspnoea and required oxygen administration. Her respiratory condition gradually worsened. She exhibited a decreased level of consciousness, low BP and worsened respiratory status, requiring ICU admission. Her chest X-ray showed bilateral diffuse infiltration. A CT scan of her chest revealed massive consolidation, thickening of the interlobular septa and traction bronchiectasis. Diffuse intrabronchial bloody discharge was noted on bronchoscopy, and the right middle lobe was subsequently washed with normal saline. A pathological examination showed numerous nematodes in the intrabronchial discharge identified as *Strongyloides stercoralis*. She was diagnosed with *Strongyloides* hyperinfection syndrome.

The woman was treated with ivermectin and broad spectrum antibiotics. *Streptococcus gordonii*

and *Klebsiella pneumoniae* were also detected in the blood culture. The ivermectin was administered daily until the nematodes were no longer detected in the sputum. Her condition gradually improved, and she was transferred to the general ward on 19^th^ day in the ICU. Antibodies for human T-cell lymphotropic virus-1 (HTLV-1) were positive.

**Author comment:** \"*We herein report a case of acute respiratory distress syndrome (ARDS) due to strongyloides hyperinfection syndrome in a HTLV-1 carrier receiving corticosteroid therapy.*\"
